Setpoint Medical vagus nerve stimulation for RA publishes pivotal RCT results in Nature
Summary
Setpoint Medical published results of their pivotal randomized controlled trial of an implantable vagus nerve stimulator for rheumatoid arthritis in Nature in 2025. The bioelectronic medicine device leverages the cholinergic anti-inflammatory pathway to suppress systemic inflammation, demonstrating significant reduction in disease activity in patients who failed biologic therapies without immunosuppression side effects.
Why it matters
A Nature publication for a pivotal RA trial of an implantable bioelectronic device is a landmark for the bioelectronic medicine field. Nature publication of pivotal clinical trial data is extremely rare and signals both scientific significance and robust trial design that will carry substantial weight with regulators and payers worldwide.
Want the full NeurotechMag Pro intelligence database?
Access 800+ papers, trials, patents, funding rounds and news items — updated daily.
Start free trial